Concepedia

Dina Schneider

DS

34

Publications

3K

Citations

24

H-Index

2008

Active since

Affiliations

Lentigen Technology (United States)(Current)

Miltenyi Biotec (Germany)

Medical College of Wisconsin

University of Washington

University of Michigan

Dina Schneider is an author at Lentigen Technology (United States) specializing in immunology, immunotherapy, and medicine.

ORCID

Top concepts

Publications per year

2008–2024

34

Publications

34

Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial

Nirav N. Shah, Bryon D. Johnson, Dina Schneider et al. · Nature Medicine · 2020 · 439 citations

, , +7

A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines

Dina Schneider, Ying Xiong, Darong Wu et al. · Journal for ImmunoTherapy of Cancer · 2017 · 257 citations · Full text

, , +20

Role of Double-Stranded RNA Pattern Recognition Receptors in Rhinovirus-Induced Airway Epithelial Cell Responses

Qiong Wang, Deepti R. Nagarkar, Emily Bowman et al. · The Journal of Immunology · 2009 · 243 citations · Full text

, , +14

Increased Cytokine Response of Rhinovirus-infected Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease

Dina Schneider, Shyamala Ganesan, Adam T. Comstock et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 184 citations · Full text

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Haneen Shalabi, Haiying Qin, Angela Su et al. · Blood · 2022 · 164 citations · Full text

Rows per page

1–5 of 34